Synthorx, Inc. — Form D
Synthorx, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-27. The offering totals $63.7M, of which $26.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-27
- Form: D
- Accession: 0001609727-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $63.7M
- Amount sold: $26.5M
- Remaining: $37.2M
- Investors: 10
- Date of first sale: 2018-04-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311122
Issuer
- Name: Synthorx, Inc.
- CIK: 0001609727
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11099 NORTH TORREY PINES ROAD, SUITE 290, LA JOLLA, CA, 92037
- Phone: 858-750-4715
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Andrew Levin | Director | BOSTON, MA |
| Jay Lichter | Director | La Jolla, CA |
| Floyd Romesberg | Director | La Jolla, CA |
| Laura Shawver | Director | Del Mar, CA |
| Peter Thompson | Director | Chanhassen, MN |
| Laura Shawver | Executive Officer | Del Mar, CA |
| Tighe Reardon | Executive Officer | La Jolla, CA |
| Court Turner | Director | San Diego, CA |
| Court Turner | Executive Officer | San Diego, CA |
| Douglas Downs | Executive Officer | La Jolla, CA |
Other filings by this issuer (2)
More